Scarica l'app Stockscreener
11.71
1.60%
-0.19
Dopo l'orario di chiusura:
11.71
Precedente Chiudi:
$11.90
Aprire:
$11.92
Volume 24 ore:
1.20M
Relative Volume:
1.07
Capitalizzazione di mercato:
$830.75M
Reddito:
$114.04M
Utile/perdita netta:
$-330.15M
Rapporto P/E:
-2.4757
EPS:
-4.73
Flusso di cassa netto:
$-274.85M
1 W Prestazione:
+6.45%
1M Prestazione:
-1.68%
6M Prestazione:
+78.78%
1 anno Prestazione:
-32.00%
Intervallo 1D:
$11.35
$11.94
Intervallo di 1 settimana:
$11.00
$12.60
Portata 52W:
$2.21
$19.50
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
Nome
Phathom Pharmaceuticals Inc
Settore
Industria
Telefono
(877) 742-8466
Indirizzo
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Confronta PHAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHAT
Phathom Pharmaceuticals Inc
|
11.71 | 844.23M | 114.04M | -330.15M | -274.85M | -4.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-03 | Iniziato | Stifel | Buy |
| 2024-01-05 | Reiterato | Needham | Buy |
| 2023-08-09 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-13 | Iniziato | Craig Hallum | Buy |
| 2022-10-21 | Iniziato | Jefferies | Buy |
| 2022-05-06 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-05-12 | Aggiornamento | Goldman | Sell → Neutral |
| 2021-02-17 | Iniziato | BMO Capital Markets | Outperform |
| 2021-02-02 | Iniziato | Guggenheim | Buy |
| 2020-06-26 | Downgrade | Goldman | Neutral → Sell |
| 2019-11-20 | Iniziato | Evercore ISI | Outperform |
| 2019-11-19 | Iniziato | Goldman | Neutral |
| 2019-11-19 | Iniziato | Jefferies | Buy |
| 2019-11-19 | Iniziato | Needham | Buy |
Mostra tutto
Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie
Phathom Pharmaceuticals CFO Molly Henderson sells shares worth $43,370 - MSN
Goldman Sachs Group Inc. Cuts Stake in Phathom Pharmaceuticals, Inc. $PHAT - Defense World
Phathom Pharmaceuticals, Inc. $PHAT Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Market Moves: Is Phathom Pharmaceuticals Inc. a top pick in the sector2025 Key Lessons & Community Verified Swing Trade Signals - خودرو بانک
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 4.1%Time to Sell? - MarketBeat
MACD Signal: How does C F Financial Corporation correlate with NasdaqIPO Watch & AI Based Trade Execution Alerts - khodrobank.com
Will Phathom Pharmaceuticals Inc. stock recover after recent drop2025 Big Picture & Safe Entry Zone Identification - newser.com
Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's Why - Yahoo Finance
Dip Buying: What is Phathom Pharmaceuticals Incs book value per shareJuly 2025 Gainers & Entry Point Confirmation Alerts - خودرو بانک
Meme Stocks: Does Phathom Pharmaceuticals Inc. stock have upside surprise potentialEarnings Overview Summary & Community Verified Trade Alerts - خودرو بانک
Real time alert setup for Phathom Pharmaceuticals Inc. performanceEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Bull Bear: Can Phathom Pharmaceuticals Inc. weather a recessionTrade Volume Summary & Technical Entry and Exit Alerts - khodrobank.com
Woodline Partners LP Has $4.71 Million Stock Holdings in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Investor Mood: Is Phathom Pharmaceuticals Inc backed by strong institutional buyingDay Trade & Fast Entry and Exit Trade Plans - خودرو بانک
Applying Elliott Wave Theory to Phathom Pharmaceuticals Inc.Weekly Trend Report & Community Trade Idea Sharing Platform - newser.com
Quarterly Trades: Is Phathom Pharmaceuticals Inc backed by strong institutional buyingJuly 2025 Volume & Fast Entry High Yield Tips - خودرو بانک
Jobs Data: What hedge funds are buying Phathom Pharmaceuticals Inc2025 Historical Comparison & Precise Entry and Exit Recommendations - خودرو بانک
Recap Report: How correlated is Phathom Pharmaceuticals Inc to the S P5002025 Market Outlook & Accurate Entry and Exit Point Alerts - خودرو بانک
Phathom Pharmaceuticals (NASDAQ:PHAT investor five-year losses grow to 69% as the stock sheds US$66m this past week - simplywall.st
Pullback Watch: Is Phathom Pharmaceuticals Inc a strong growth stockJuly 2025 Highlights & Free Reliable Trade Execution Plans - خودرو بانک
Jacobs Levy Equity Management Inc. Invests $3.74 Million in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Fund Flows: Is Phathom Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Levels & Fast Moving Trade Plans - خودرو بانک
Profit Review: Is Phathom Pharmaceuticals Inc forming a breakout patternProduct Launch & Daily Risk Controlled Trade Plans - خودرو بانک
Craig-Hallum Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating - 富途牛牛
Phathom says FDA confirmed Voqueza exclusivity through May 2032 - MSN
Phathom Pharmaceuticals officer sells $5573 in stock By Investing.com - Investing.com Canada
Phathom Pharmaceuticals officer sells $5573 in stock - Investing.com
101,520 Shares in Phathom Pharmaceuticals, Inc. $PHAT Purchased by Nuveen LLC - MarketBeat
Wall Street Analysts See a 66.13% Upside in Phathom Pharmaceuticals (PHAT): Can the Stock Really Move This High? - Yahoo Finance
Recovery Signals Appearing in Phathom Pharmaceuticals Inc. Charts2025 EndofYear Setup & Weekly High Return Stock Opportunities - beatles.ru
Phathom Pharmaceuticals: The IP Question Is Answered, But Can Management Deliver (Rating Upgrade) - Seeking Alpha
Chart based analysis of Phathom Pharmaceuticals Inc. trendsOil Prices & Capital Protection Trade Alerts - Newser
Is Phathom Pharmaceuticals Inc. stock overvalued or fairly pricedGDP Growth & Expert Verified Stock Movement Alerts - خودرو بانک
Russell Investments Group Ltd. Invests $262,000 in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Aug Breakouts: Can Phathom Pharmaceuticals Inc. weather a recession2025 Technical Overview & Community Verified Watchlist Alerts - خودرو بانک
Signal strength of Phathom Pharmaceuticals Inc. stock in tech scanners2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Visual analytics tools that track Phathom Pharmaceuticals Inc. performanceCEO Change & Consistent Growth Equity Picks - Newser
What the charts say about Phathom Pharmaceuticals Inc. todayWeekly Risk Summary & AI Enhanced Trading Signals - Newser
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
What recovery options are there for Phathom Pharmaceuticals Inc.2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
How to forecast Phathom Pharmaceuticals Inc. trends using time series2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Institutional scanner results for Phathom Pharmaceuticals Inc.Earnings Performance Report & AI Driven Stock Movement Reports - Newser
Is Phathom Pharmaceuticals Inc. building a consolidation base2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Has Phathom Pharmaceuticals Inc. formed a bullish divergenceMarket Performance Summary & Capital Protection Trade Alerts - Newser
How hedge fund analytics apply to Phathom Pharmaceuticals Inc. stock2025 Key Lessons & Daily Volume Surge Trade Alerts - Newser
Detecting support and resistance levels for Phathom Pharmaceuticals Inc.Trade Volume Summary & Growth Focused Entry Point Reports - Newser
What’s next for Phathom Pharmaceuticals Inc. stock priceWeekly Investment Recap & AI Based Buy and Sell Signals - Newser
Will Phathom Pharmaceuticals Inc. stock recover after earningsStock Surge & Accurate Intraday Trading Signals - خودرو بانک
Is Phathom Pharmaceuticals Inc. a turnaround storyWeekly Trade Analysis & Verified Short-Term Trading Plans - خودرو بانک
Is Phathom Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Drop Watch & Risk Managed Investment Signals - خودرو بانک
Phathom Pharmaceuticals Inc Azioni (PHAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):